瑞博生物-B(06938)：超额配股权获悉数行使稳定价格期结束

智通财经02-05

智通财经APP讯，瑞博生物-B(06938)公布，整体协调人(为其本身及代表国际承销商)已于2026年2月5日(星期四)悉数行使招股章程所述的超额配股权，涉及合共474.14万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股57.97港元发行及配发。超额配发股份将用于补足国际发售的超额分配。此外，有关全球发售...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2609097903?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-05 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609097903","market":"hk","top_or_hot":-1,"title":"瑞博生物-B(06938)：超额配股权获悉数行使 稳定价格期结束","media":"智通财经","content":"<div>\n<p>智通财经APP讯，瑞博生物-B(06938)公布，整体协调人(为其本身及代表国际承销商)已于2026年2月5日(星期四)悉数行使招股章程所述的超额配股权，涉及合共474.14万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股57.97港元发行及配发。超额配发股份将用于补足国际发售的超额分配。此外，有关全球发售...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1402289.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞博生物-B(06938)：超额配股权获悉数行使 稳定价格期结束</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞博生物-B(06938)：超额配股权获悉数行使 稳定价格期结束\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-05 22:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1402289.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，瑞博生物-B(06938)公布，整体协调人(为其本身及代表国际承销商)已于2026年2月5日(星期四)悉数行使招股章程所述的超额配股权，涉及合共474.14万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股57.97港元发行及配发。超额配发股份将用于补足国际发售的超额分配。此外，有关全球发售...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1402289.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06938","symbol_name":"瑞博生物-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1402289.html","article_id":"2609097903","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609097903","pubTimestamp":1770302154,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，瑞博生物-B(06938)公布，整体协调人(为其本身及代表国际承销商)已于2026年2月5日(星期四)悉数行使招股章程所述的超额配股权，涉及合共474.14万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股57.97港元发行及配发。超额配发股份将用于补足国际发售的超额分配。此外，有关全球发售的稳定价格期已于2026年2月5日(星期四)(即递交香港公开发售申请截止日期后第30日)结束。于稳定价格期，稳定价格操作人并无为稳定价格而在市场上买卖任何H股。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06938":"瑞博生物-B","BK1161":"生物科技"},"translate_title":"Ruibo Bio-B (06938): The over-allotment option is fully exercised and the price stabilization period ends","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06938":1.5},"content_text":"智通财经APP讯，瑞博生物-B(06938)公布，整体协调人(为其本身及代表国际承销商)已于2026年2月5日(星期四)悉数行使招股章程所述的超额配股权，涉及合共474.14万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股57.97港元发行及配发。超额配发股份将用于补足国际发售的超额分配。此外，有关全球发售的稳定价格期已于2026年2月5日(星期四)(即递交香港公开发售申请截止日期后第30日)结束。于稳定价格期，稳定价格操作人并无为稳定价格而在市场上买卖任何H股。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609097903","isCrawlerRequest":true}

瑞博生物-B(06938)：超额配股权获悉数行使 稳定价格期结束

精彩评论

瑞博生物-B(06938)：超额配股权获悉数行使稳定价格期结束